en

PRODUCT DETAIL

Ogivri 150 mg prášok na infúzny koncentrát

Code 9997C
MA number EU/1/18/1341/001
Product Form: plc ifc 1x150 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XC Monoclonal antibodies
L01XC03 Trastuzumab
Shelf life: 48
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 12.12.2018
Validity: 12.12.2023
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 11.01.2019
eu-flag.png sk-flag.png